Clinical efficacy of an anticolinergic agent in HAM/TPS patients with neurogenic bladder

被引：0

作者：

de Castro, Neviton Matos ^{[1
]}

Freitas, Daniel Meira ^{[1
]}

Rodrigues, Waldyr, Jr. ^{[2
]}

Oliveira, Paulo ^{[2
]}

Muniz, Andre ^{[3
]}

de Carvalho, Edgar Marcelino ^{[3
]}

机构：

[1] Univ Fed Bahia, Brazilian Soc Urol, Salvador, BA, Brazil

[2] Univ Fed Bahia, Dept Immunol, Salvador, BA, Brazil

[3] Univ Fed Bahia, Dept Neurol, Salvador, BA, Brazil

来源：

EINSTEIN-SAO PAULO | 2005年 / 3卷 / 04期

关键词：

Human T-lymphotropic virus 1; Paraparesis; tropical spastic; Cholinergic antagonists; Bladder; neurogenic;

D O I：

暂无

中图分类号：

R5 [内科学];

学科分类号：

1002 ; 100201 ;

摘要：

Objective: To describe the efficacy of the propantheline bromide in neurogenic bladder in HTLV-I infected patients. Methods: From January/2001 to February/2004, twenty-one HTLV-I-carriers (7 men and 14 women) were selected for treatment with propantheline bromide 15 mg, PO, 2 to 3 times a day for 3 months, not discontinuing in the follow-up. At the end of the treatment period, patients were revaluated through specific questionnaires for urinary symptoms (UDI) and quality of life (Ditrovie). Results: From the 21 patients enrolled, 15 (71.4%) presented important clinical improvement, referring decrease of urinary frequency, urgency and loss, nocturia, and even total control of the dysfunction. Conclusion: We observed an efficient response to the anticholinergic agent propantheline bromide in urinary dysfunction caused by the HTLV-1

引用

页码：251 / 254

页数：4

共 50 条

[1] EFFICACY OF ONABOTULINUMTOXINA IN PATIENTS WITH NEUROGENIC BLADDER AND DECREASED BLADDER COMPLIANCE
Mengheang, Laura
Hairston, John
Smith, Christopher
JOURNAL OF UROLOGY, 2011, 185 (04): : E608 - E608
[2] SAFETY AND EFFICACY OF PERCUTANEOUS NEPHROLITHOTOMY IN PATIENTS WITH NEUROGENIC BLADDER
Chelghaf, Ismael
Glemain, Pascal
Madec, Francois-Xavier
Le Normand, Loic
Rigaud, Jerome
Branchereau, Julien
Perrouin-Verbe, Marie-Aimee
JOURNAL OF UROLOGY, 2019, 201 (04): : E330 - E330
[3] Safety and efficacy of percutaneous nephrolithotomy in patients with neurogenic bladder
Chelghaf, I.
Glemain, P.
Madec, F. X.
Loubersac, T.
de Vergie, S.
Branchereau, J.
Rigaud, J.
Perrouin-Verbe, B.
Lefort, M.
Perrouin-Verbe, M. A.
PROGRES EN UROLOGIE, 2022, 32 (06): : 442 - 450
[4] Efficacy of Percutaneous Nephrolithotomy in Patients with Neurogenic Bladder Dysfunction
Tepeler, Abdulkadir
Karadag, Mert Ali
Tok, Adem
Akcay, Muzaffer
Binbay, Murat
Berberoglu, Yalcin
Tefekli, Ahmet
Muslumanoglu, Ahmet Yaser
HASEKI TIP BULTENI-MEDICAL BULLETIN OF HASEKI, 2010, 48 (02): : 76 - 79
[5] Detrusor Arreflexia as an End Stage of Neurogenic Bladder in HAM/TSP?
Tannus, Matheus
Tanajura, Davi
Sundberg, Michael A.
Oliveira, Paulo
Castro, Neviton
Santos, Andre Emuniz
CASE REPORTS IN MEDICINE, 2011, 2011
[6] Safety and efficacy of percutaneous nephrolithotomy in patients with neurogenic bladder dysfunction
Rubenstein, JN
Gonzalez, CM
Blunt, LW
Clemens, JQ
Nadler, RB
UROLOGY, 2004, 63 (04) : 636 - 640
[7] Morbidity and Efficacy of Ureteroscopic Stone Treatment in Patients with Neurogenic Bladder
Christman, Matthew S.
Kalmus, Angela
Casale, Pasquale
JOURNAL OF UROLOGY, 2013, 190 (04): : 1479 - 1483
[8] Safety and efficacy of percutaneous nephrolithotomy in patients with neurogenic bladder dysfunction
Rubenstein, JN
Gonzalez, CM
Bushman, W
Clemens, Q
Nadler, RB
JOURNAL OF UROLOGY, 2003, 169 (04): : 490 - 490
[9] Clinical and urodynamic evaluation of efficacy intradetrusor botulinum toxin A (BIA) injections in patients with neurogenic overactive bladder
Game, Xavier
Castel-Lacanal, Evelyne
Guillotreau, Julien
Sallusto, Federico
De Boissezon, Xavier
Malavaud, Bernard
Marque, Philippe
Rischmann, Pascal
Sarramon, Jean-Pierre
E-MEMOIRES DE L ACADEMIE NATIONALE DE CHIRURGIE, 2008, 7 (04): : 1 - 4
[10] CLINICAL PHARMACOLOGY OF NEUROGENIC BLADDER
PEDERSEN, E
GRYNDERUP, V
ACTA NEUROLOGICA SCANDINAVICA, 1966, S 42 : 111 - +

← 1 2 3 4 5 →